Breaking News
Sort by:
Top Post
ProBioGen and ImmunOs Therapeutics Team Up to Deliver Innovative Therapy for Cancer Patients
ProBioGen, a Berlin-based specialist for developing and manufacturing biopharmaceutical active ingredients, viral vectors and vaccines, and […]
NRx Pharmaceuticals Appoints Ira Strassberg as Chief Financial Officer and Treasurer
NRx Pharmaceuticals, Inc. (Nasdaq: NRXP), a clinical-stage pharmaceutical company, announced today that the company’s Board of Directors […]
enGene Appoints James C. Sullivan, PhD as Chief Scientific Officer
enGene Inc., a clinical-stage biotechnology company pioneering novel non-viral gene therapies for local administration into mucosal […]
KeyZell Start-up Plans to Reach 5 Million Euros in Private Investment and Become the New Biotech Unicorn
KeyZell, a Spanish biotechnology company in the development phase of digital cancer treatments and tools, […]
Sanofi and Seagen Announce Collaboration to Develop and Commercialize Multiple Novel Antibody-drug Conjugates
Sanofi and Seagen Inc. (Nasdaq:SGEN) today announced an exclusive collaboration agreement to design, develop, and commercialize antibody-drug conjugates […]
Virpax Pharmaceuticals Expands AnQlar™ Development and Commercialization Rights Through Worldwide Licensing Agreement
Virpax® Pharmaceuticals, Inc. (“Virpax” or the “Company”) (NASDAQ: VRPX), a company specializing in developing non-addictive […]
Sanofi Announces €300 Million Collaboration with Blackstone Life Sciences to Advance an Innovative Treatment for Multiple Myeloma
Sanofi and Blackstone (NYSE: BX) today announced a strategic, risk-sharing collaboration under which funds managed […]
Nosopharm Signs Partnership with INRAE and University of Montpellier to Develop New Anti-infectives
Nosopharm, specialized in exploring unconventional sources of antibiotics to discover new drugs to fight antimicrobial […]
Elevation Oncology Appoints David Dornan, Ph.D., as Chief Scientific Officer
Elevation Oncology, Inc. (Nasdaq: ELEV), a clinical-stage biopharmaceutical company focused on the development of precision medicines […]
Seabelife Receives Close to €1.4m Deep Tech Financing from Bpifrance
SeaBeLife, a biotech company developing drug candidates intended to block cell necrosis, today announces that […]
Curebase and Blue Note Therapeutics Collaborate on Home-based Clinical Trial of Prescription Digital Therapeutics to Help People with Cancer Manage their Health
Curebase, a company committed to democratizing access to clinical studies, and Blue Note Therapeutics, a prescription […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more